Paradigm Biocapital Advisors LP Q2 2023 Filing
Filed August 14, 2023
Portfolio Value
$1.3T
Holdings
29
Report Date
Q2 2023
Filing Type
13F-HR
All Holdings (29 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | LEGNLEGEND BIOTECH CORP | 1,805,717 | $124.6B | 9.63% | |
| 2 | ARGXARGENX SE | 292,259 | $113.9B | 8.80% | Put |
| 3 | INCYINCYTE CORP | 1,381,711 | $86.0B | 6.65% | |
| 4 | IMCRIMMUNOCORE HLDGS PLC | 1,270,124 | $76.2B | 5.88% | |
| 5 | ACLXARCELLX INC | 2,347,000 | $74.2B | 5.73% | |
| 6 | KRTXKARUNA THERAPEUTICS INC | 283,605 | $61.5B | 4.75% | |
| 7 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 1,868,946 | $59.4B | 4.59% | |
| 8 | VRDNVIRIDIAN THERAPEUTICS INC | 2,415,256 | $57.5B | 4.44% | |
| 9 | UTHUNITED THERAPEUTICS CORP DEL | 238,388 | $52.6B | 4.07% | |
| 10 | MRTXEURMIRATI THERAPEUTICS INC | 1,443,762 | $52.2B | 4.03% | |
| 11 | SNDXSYNDAX PHARMACEUTICALS INC | 2,424,132 | $50.7B | 3.92% | |
| 12 | BCYCBICYCLE THERAPEUTICS PLC | 1,985,430 | $50.7B | 3.92% | |
| 13 | NUVLNUVALENT INC | 1,120,465 | $47.3B | 3.65% | |
| 14 | ONCBEIGENE LTD | 216,093 | $38.5B | 2.98% | |
| 15 | XENEXENON PHARMACEUTICALS INC | 989,327 | $38.1B | 2.94% | |
| 16 | OLMAOLEMA PHARMACEUTICALS INC | 3,731,046 | $33.7B | 2.60% | |
| 17 | —AMBRX BIOPHARMA INC | 1,650,499 | $27.2B | 2.10% | |
| 18 | CRNXCRINETICS PHARMACEUTICALS IN | 1,395,002 | $25.1B | 1.94% | |
| 19 | NVLSEURALPINE IMMUNE SCIENCES INC | 2,423,961 | $24.9B | 1.93% | |
| 20 | VIRVIR BIOTECHNOLOGY INC | 1,014,239 | $24.9B | 1.92% | |
| 21 | ZLABZAI LAB LTD | 865,297 | $24.0B | 1.85% | |
| 22 | IMTXIMMATICS N.V | 1,984,813 | $22.9B | 1.77% | |
| 23 | AUTLAUTOLUS THERAPEUTICS PLC | 9,217,150 | $21.9B | 1.70% | |
| 24 | VORVOR BIOPHARMA INC | 6,461,467 | $20.0B | 1.54% | |
| 25 | MDGLMADRIGAL PHARMACEUTICALS INC | 85,000 | $19.6B | 1.52% | |
| 26 | VRNAVERONA PHARMA PLC | 893,861 | $18.9B | 1.46% | |
| 27 | MLTXMOONLAKE IMMUNOTHERAPEUTICS | 369,615 | $18.9B | 1.46% | |
| 28 | —THESEUS PHARMACEUTICALS INC | 1,950,327 | $18.2B | 1.41% | |
| 29 | KURAKURA ONCOLOGY INC | 1,004,908 | $10.6B | 0.82% |